Skip to content

Travel-Imported Arbovirus infections and mHealth applications for outbreak Risk Assessment: ZIeKA monitor part 2

Travel-Imported Arbovirus infections and mHealth applications for outbreak Risk Assessment: ZIeKA monitor part 2 - ZIeKA monitor part 2

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON48637
Enrollment
348
Registered
2018-10-03
Start date
2018-11-01
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

arbovirus infections mosquito-born infections

Interventions

None listed

Sponsors

RIVM
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: adult travelers, traveling to areas with risk of arbovirus infections.These adult travelers are participants of part one of the ZIeKA monitor.

Exclusion criteria

Exclusion criteria: not willing to collect blood with finger prick

Design outcomes

Primary

MeasureTime frame
The proportion of PCR positive samples containing arboviruses (Dengue, Chikungunya, Zika, Gele koorts) in travelers.

Secondary

MeasureTime frame
The proportion of positive serology samples of arbovirus (Dengue, Chikungunya, Zika, Gele koorts) specific IgM en/of IgG in travelers who developed health complaints during their trip.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)